" class="no-js "lang="en-US"> NuvoAir - Medtech Alert
Thursday, September 21, 2023

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
NuvoAir | Pharmtech Focus

NuvoAir

About NuvoAir

NuvoAir

NuvoAir offers a care platform designed to support people with respiratory conditions achieve better outcomes, providers make the right clinical decisions and health plans achieve higher ROI.

Related Story

Clinical Trials

 Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials | Pharmtech Focus

Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials

September 8 2022

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced a […]

Diseases

 NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment | Pharmtech Focus|Peter Bradding

NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment

May 26 2022

NuvoAir’s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as […]

Fundraising

 NuvoAir Series A Funding Reaches $25M to Expand Patient-Centric Care and Clinical Trials Platform | Pharmtech Focus

NuvoAir Series A Funding Reaches $25M to Expand Patient-Centric Care and Clinical Trials Platform

January 20 2022

NuvoAir, a leading digital healthcare company working in chronic disease management, raised $11M in a […]

Diseases

 NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma | Pharmtech Focus

NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma

August 27 2021

Three new studies show how home monitoring technology – developed by leading digital health company NuvoAir – […]

Diseases

 NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions | Pharmtech Focus

NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions

June 23 2021

NuvoAir – the digital health company on a mission to improve the lives of millions […]